McKesson agreed to pay a $150 million civil penalty for alleged similar violations of the Controlled Substances Act regarding the distribution of opioids. In May 2020, Oklahoma Attorney General Mike Hunter sued McKesson in Bryan County District Court, Oklahoma. The lawsuit alleged that the company's actions helped fuel Oklahoma's opioid crisis. The suit was filed along with lawsuits against Cardinal Health and AmerisourceBergen, and the three lawsuits allege that the three companies provided "enough opioids to Bryan County that every adult resident there could have had 144 hydrocodone tablets." In January 2022, McKesson, AmerisourceBergen, Cardinal Health, and Johnson & Johnson agreed to pay $26 billion to settle with all but five of the states suing them. Had the states gone to court, the companies could have faced up to $95 billion in penalties. Covid-19 Centralized Vaccine Distributor In August 2020 during the COVID-19 pandemic, the CDC and HHS selected McKesson as the U.S. government's centralized distributor for Covid-19 vaccine doses and ancillary supply kits under Operation Warp Speed, highlighting the company's long-standing role as major vaccine distributor in the United States (including its position as the largest distributor of the seasonal flu vaccine). The company has played a key role in distributing the Moderna and Johnson & Johnson vaccines while also distributing ancillary supply kits for these as well as for the Pfizer–BioNTech vaccine across the U.S. (in addition to supporting the U.S. government in efforts to send doses and kits abroad). As of May 5, 2022, McKesson had distributed over 380 million vaccine doses and delivered supply kits to support over 1.2 billion vaccines doses throughout the United States. International McKesson Canada In 1991, McKesson Corporation acquired a 100 percent interest in Medis Health and Pharmaceutical Services from Provigo. In 2002, the McKesson Canada name was adopted. McKesson Canada is a wholly owned subsidiary of McKesson Corporation. It includes various business units: McKesson Pharmaceutical, McKesson Automation, McKesson Specialty, McKesson Health Solutions and McKesson Information Solutions. McKesson agreed to purchase Canadian pharmacy chain The Medicine Shoppe from the Katz Group of Companies https://www.medicineshoppe.ca/en/who-we-are/who-we-are In March 2016, McKesson agreed to purchase Canadian pharmacy chain Rexall from the Katz Group of Companies for $3 billion. The deal was finalized in December 2016 following approval received under the Investment Canada Act. In May 2018, McKesson Canada closed 40 Rexall locations in Ontario and Western Canada. United Kingdom In the United Kingdom, McKesson (operating